Incidence and clinical implications of venous thromboembolism in advanced colorectal cancer patients: The ‘GISCAD-alternating schedule’ study findings
- 31 January 2009
- journal article
- research article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 45 (1), 65-73
- https://doi.org/10.1016/j.ejca.2008.09.005
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Updated efficacy and toxicity analysis of irinotecan and oxaliplatin (IROX)Cancer, 2007
- Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II studyBritish Journal of Cancer, 2007
- Capecitabine plus oxaliplatin (xelox) versus protracted 5-fluorouracil venous infusion plus oxaliplatin (pvifox) as first-line treatment in advanced colorectal cancer: A GOAM phase II randomised study (FOCA trial)European Journal Of Cancer, 2006
- Venous thromboembolism and cancer: Guidelines of the Italian Association of Medical Oncology (AIOM)Critical Reviews in Oncology/Hematology, 2006
- Randomised phase II study of standard versus chronomodulated CPT-11 plus chronomodulated 5-fluorouracil and folinic acid in advanced colorectal cancer patientsEuropean Journal Of Cancer, 2006
- Randomised Phase III study of biweekly 24-h infusion of high-dose 5FU with folinic acid and oxaliplatin versus monthly plus 5-FU/folinic acid in first-line treatment of advanced colorectal cancerAnnals of Oncology, 2006
- Randomised study of tegafur and oral leucovorin versus intravenous 5-fluorouracil and leucovorin in patients with advanced colorectal cancerEuropean Journal Of Cancer, 2005
- Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomized, phase II studyAnnals of Oncology, 2005
- Oxaliplatin plus high-dose folinic acid and 5-fluorouracil i.v. bolus (OXAFAFU) versus irinotecan plus high-dose folinic acid and 5-fluorouracil i.v. bolus (IRIFAFU) in patients with metastatic colorectal carcinoma: a Southern Italy Cooperative Oncology Group phase III trialAnnals Of Oncology, 2005
- The Thrombogenic Effect of Anticancer Drug Therapy in Women with Stage II Breast CancerNew England Journal of Medicine, 1988